Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis
- 1 August 2018
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 70 (8), 1245-1250
- https://doi.org/10.1002/acr.23470
Abstract
Objective. Health inequities exist in chronic diseases for Aboriginal people. This study compared early rheumatoid arthritis (RA) presentation, treatment, and outcomes between Aboriginal and white patients in a large Canadian cohort study. Methods. Longitudinal data from the Canadian Early Arthritis Cohort, a prospective multicenter early RA study, were analyzed for participants who self-identified as Aboriginal or white ethnicity. Disease characteristics at presentation, prognostic factors, frequency of remission, and disease-modifying therapy strategies were contrasted between population groups. Linear mixed models were used to estimate rates of change for disease activity measures over a 5-year period. Results. At baseline, 2,173 participants (100 Aboriginal and 2,073 white) had similar mean +/- SD symptom duration (179 +/- 91 days), 28-joint Disease Activity Scores (DAS28; 4.87 +/- 1.48), and Health Assessment Questionnaire (0.88 +/- 0.68) scores. Factors associated with poor prognosis were more frequently present in Aboriginal participants, but disease-modifying therapy selection and frequency of therapy escalation was similar between the 2 groups. DAS28 remission was achieved less frequently in Aboriginal than in white participants (adjusted odds ratio 0.39 [95% confidence interval 0.25-0.62]). Results were primarily driven by slower improvement in swollen joint counts and nonsignificant improvement in patient global scores in Aboriginal participants. Pain levels remained higher in Aboriginal patients. Conclusion. Aboriginal early RA patients experienced worse disease outcomes than their white counterparts. This may reflect unmeasured biologic differences and/or disparities in prognostic factors informed by inequities in determinants of health. The appropriateness of current treatment strategies applied in different contexts should be considered.Keywords
Funding Information
- McCaig Institute for Bone and Joint Health
- Canadian Institutes for Health Research Foundation Scheme (FDN 143284)
This publication has 11 references indexed in Scilit:
- Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritisCurrent Opinion in Rheumatology, 2017
- Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New ZealandRheumatology International, 2016
- Access to primary health care services for Indigenous peoples: A framework synthesisInternational Journal for Equity in Health, 2016
- Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non–First Nations Populations of Alberta, CanadaArthritis Care & Research, 2016
- Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy ControlsArthritis & Rheumatology, 2016
- Discordant indigenous and provider frames explain challenges in improving access to arthritis care: a qualitative study using constructivist grounded theoryInternational Journal for Equity in Health, 2014
- The Canadian Early Arthritis Cohort (CATCH): Patients with New-onset Synovitis Meeting the 2010 ACR/EULAR Classification Criteria But Not the 1987 ACR Classification Criteria Present with Less Severe Disease ActivityThe Journal of Rheumatology, 2012
- Vitamin D Receptor Polymorphism rs2228570 (Fok1) Is Associated with Rheumatoid Arthritis in North American NativesThe Journal of Rheumatology, 2012
- Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native populationGenes & Immunity, 2011
- Antibodies toPorphyromonas gingivalisAre Associated with Anticitrullinated Protein Antibodies in Patients with Rheumatoid Arthritis and Their RelativesThe Journal of Rheumatology, 2010